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I INTRODUCTION
 Down syndrome, the most frequent form of mental retardation caused
by a microscopically demonstrable chromosomal aberration, is characterized
by well  defined and distinctive phenotypic features and natural history.  It is
caused by  the triplicate state of all or a  critical  portion of   chromosome 21.
In 1866, John Langdon Down 1 wrote,
 “The face is flat and broad and destitute of prominence. The  cheeks
are round and extended laterally. The eyes are obliquely placed, and the
internal canthi more than normally distant from one another. The palpebral
fissure is very narrow; the lips are large and thick with transverse fissures.
The tongue is long, thick and is much roughened. The nose is small.”
 This description of the clinical characteristics of the syndrome, which
bears his name is a common genetic disorder with an overall incidence of
1in 800 2. All individuals with Down syndrome have extra chromosome 21
material. Children with Down syndrome have multiple malformations and
mental retardation due to the presence of extra genetic material from
chromosome 21. Although the phenotype is variable, usually there is enough
consistency to enable the experienced clinician to suspect the diagnosis.
Down syndrome decreases prenatal viability and increases prenatal and
postnatal morbidity. Affected children have delayed physical growth,
maturation, bone development, and dental eruption.
Genetics
It is the common genetic disorder occurring in 1/800 live newborns.
John Langdon Down 1866 : First description
Lejeune 1959   : Three copies of chromosome 21
Hattori et al 2000   : DNA sequencing of
chromosome 21
Information on Chromosome 21 3
• Smallest human autosome, “gene-poor”
• 33.8 mega bases (Mb)
• 225 genes: 127 known, 98 predicted
• DSCAM largest gene, 840 kb
• Contains locus for predisposition to AML
• Contains tumor suppressor gene
 The extra copy of the proximal part of 21q22.3 appears to result in
the typical physical phenotype. Molecular analysis reveals that the 21q22.1-
q22.3 region, or Down syndrome critical region (DSCR), appears to contain
the gene or genes responsible for the congenital heart disease observed in
Down syndrome. A new gene, DSCR1, identified in region 21q22.1-q22.2,
is highly expressed in the brain and the heart and is a candidate for
involvement in the pathogenesis of Down syndrome, particularly in mental
retardation and/or cardiac defects.
There are three main forms of Down syndrome, all of them a form of
partial or complete aneuploidy.
Trisomy 21 due to non-disjunction
By far the most common form is the genetic condition Trisomy 21, in
which there is an additional copy of chromosome 21; this accounts for 95%
of all cases of Down syndrome. There are normally two copies of 23
chromosomes (46 in total), but individuals with Trisomy 21 have three
copies of chromosome 21 (47 in total). Trisomy 21 is caused by a process
called non-disjunction, a form of faulty cell division (generally occurring
during meiosis) prior to or at conception that results in an embryo with three
copies of chromosome 21 instead of two. As the embryo develops, the extra
chromosome is replicated in every cell of the body.
Using DNA markers, it is possible to determine the parental origin of
the extra chromosome in Trisomy 21. Studies of several hundred families
with Down children have shown that nearly 95% of cases are of maternal
origin, although a study of second trimester prenatally diagnosed cases of
Trisomy 21 found a lower proportion of only 89% to be of maternal origin.
The risk of errors in cell division leading to Trisomy 21 increases with
maternal age.
Following the birth of a child with Trisomy 21 Down Syndrome, the
risk of subsequent children also having Down Syndrome is about one in 100.
The incidence of miscarriage in pregnancies where the fetus has Trisomy 21
is increased over that for fetuses without chromosomal abnormalities.
Mosaicism
A much rarer form of Down syndrome is a condition known as
mosaicism, which accounts for only 1-2% of all cases of Down syndrome.
Mosaicism occurs when nondisjunction of chromosome 21 takes place in
one of the initial cell divisions after fertilization, resulting in a mixture of
two types of cells in the body, some with 46 and some with 47
chromosomes. The physical features of Down syndrome may be milder in
individuals with mosaicism Trisomy 21, especially if the proportion of
normal cells is large. As with standard Trisomy 21, the risk that subsequent
children born to the parents of a child with mosaicism Down Syndrome will
also have Down Syndrome is around 1 in 100.
Translocation
Translocation is another form of chromosomal defect caused by faulty
cell division prior to or at conception; in this instance chromosome 21
attaches to another chromosome (usually 14) forming a single chromosome,
referred to as chromosome t(14;21) in the case of translocation between
chromosomes 21 and 14. All the cells in the body have two copies of
chromosome 21, one of 14, and one t(14;21); this means that there are
effectively three copies of chromosomes 21, which results in Down
syndrome. Translocation accounts for 3-4% of all cases of Down Syndrome.
 Up to one-third of cases of translocation Down Syndrome have a
familial (inherited) basis; the rest are sporadic. Examination of the
chromosomes can determine whether a parent carries the translocation.
Unaffected carriers are said to be balanced, having one copy each of
chromosomes 21, 14, and t(14;21); there is no extra chromosomal material
and hence no features of Down syndrome present. The chance of subsequent
children having Down child is around 15% if the mother is a balanced
carrier of a t(14;21) translocation, but only around 2.5% if the father is the
carrier.The frequency of translocation Down syndrome is not affected by
maternal age. A 21,22 Robertsonian translocation may also give  rise to
Down syndrome in similar way.Very rarely a 21,21 translocation may arise.
Carriers of this 21, 21 translocation can only produce zygotes that are either
monosomic or trisomic for chromosome 21, their risk of producing a child
with Trisomy 21 is virtually 100%.
Down syndrome and maternal age 5
 Researchers have established that the likelihood that a reproductive
cell will contain an extra copy of chromosome 21 increases dramatically as a
woman ages. Therefore, an older mother is more likely than a younger
mother to have a baby with Down syndrome. However, of the total
population, older mothers have fewer babies; about 75% of babies with
Down syndrome are born to younger women because more younger women
than older women have babies. Only about nine percent of total pregnancies
occur in women 35 years or older each year, but about 25% of babies with
Down syndrome are born to women in this age group.
 The incidence of Down syndrome rises with increasing maternal age.
Most specialists recommend that women who become pregnant at age 35 or
older undergo prenatal testing for Down syndrome. The likelihood that a
woman under 30 who becomes pregnant will have a baby with Down
syndrome is less than 1 in 1000, but the chance of having a baby with Down
syndrome increases to 1 in 400 for women who become pregnant at age 35.
The likelihood of Down syndrome continues to increase as a woman ages, so
that by age 42, the chance is 1 in 60 that a pregnant woman will have a baby
with Down syndrome, and by age 49, the chance is 1 in 12.
Down syndrome incidence to maternal age 5
Physical features
Shortly after birth, Down syndrome is diagnosed by recognizing
dysmorphic features and the distinctive phenotype.
 David S. Newberger 6 from The State University of New York in his
article “Down syndrome: Prenatal Risk Assessment and Diagnosis” has
identified the dysmorphic signs of Down syndrome.
Maternal age Incidence of Down syndrome
Under 30 Less than 1 in 1000
30 1 in 900
35 1 in 400
38 1 in 180
40 1 in 105
42 1 in 60
44 1 in 32
46 1 in 20
48 1 in 12
Frequency of Dysmorphic Signs in Neonates with Trisomy 21
Dysmorphic sign Frequency (%)
Flat facial profile 90
Poor Moro reflex 85
Hypotonia 80
Hyper flexibility of large joints 80
Loose skin on back of neck 80
Slanted palpebral fissures 80
Dysmorphic pelvis on radiograph 70
Small round ears 60
Hypoplasia of small finger, Middle
phalanx
60
Single palmar crease 45
Approximately 75% of conceptions with Trisomy 21 die in embryonic
or fetal life. Approximately 85% of infants survive to 1 year and 50% can be
expected to live longer than 50 years. Congenital heart disease is the most
important factor that determines survival. In addition, esophageal atresia
with or without tracheoesophageal fistula, Hirschprungs disease, duodenal
atresia and leukemia contribute to mortality. The high mortality rate later in
life may be the result of premature ageing.
Incidence of Some Associated Medical Complications in Persons with
Down syndrome 6
Disorder Incidence (%)
Mental retardation >95
Growth retardation >95
Early Alzheimer's disease Affects 75% by age 60
Congenital heart defects 40
Hearing loss 40-75
Ophthalmic disorders 60
Epilepsy 5-10
Gastrointestinal malformations 5
Hypothyroidism 5
Leukemia 1
Atlantoaxial subluxation with spinal
cord compression
<1
Increased susceptibility to infection Unknown
Infertility >99% in men; anovulation in
30% of women
Congenital Heart Disease in Down syndrome
 The association of Congenital Heart Disease in Down syndrome   was
recognized by Garrod in 1894 and Maude Abbot in 1924 1.The incidence is
about 50% compared with an incidence of 0.4% in infants with normal
chromosomes.CHD is a common cause for morbidity and mortality in early
years of life in Down syndrome.Congenital heart disease is the most
important factor that determines survival.
Down syndrome is an important variable in the proclivity for
pulmonary vascular disease 1. The proclivity does not depend on the size of
the Ventricular Septal Defect or even on the presence of congenital heart
disease. Moreover, pulmonary vascular disease occurs more rapidly in
patients with Down syndrome who have left to right shunts. So physicians
recommend routine echocardiography at the time of initial diagnosis, even in
the absence of other clinical findings 2.
Genetic Basis of Congenital Heart Disease in Down Syndrome 7
The genes for CHD are located in a small region of the long arm of
chromosome 21 from q22.1 to q22.3, the Down syndrome critical region
(DSCR). Duplication of one or more genes on chromosome 21 causes failure
of the atrioventricular septum to form properly.
The Candidate gene in Down Syndrome-CHD is DSCAM (Down
syndrome cell adhesion molecule). Increased “stickiness” of Down
syndrome endocardial cushion fibroblasts results in failure to migrate
normally.The pathogenesis of Tetralogy of Fallot may involve abnormal
migration of neural crest cells.
Down syndrome heart disease region 3
   Between 40 and 50% of babies with Down syndrome have congenital
heart defects.Of this 30-40% have complete Atrioventricular septal defects.
There must be a high level of clinical suspicion of congenital heart disease
for all newborns with the syndrome. It is essential to establish the cardiac
status of every child by age 6 weeks. Clinical examination alone is not
sufficient to detect all of even the most serious abnormalities. It must always
be remembered that despite a normal echo at birth, children with Down
syndrome, like all other children, can develop corpulmonale at a later age
secondary to airway problems.
 In Down syndrome, Atrioventricular septal defects is the most
common congenital heart disease 3 followed by Ventricular septal defect,
Atrial Septal defect (ostium secundum type), Patent ductus arteriosus and
Tetralogy of Fallot.
Down syndrome is not associated 3 with left heart obstructive lesions,
muscular VSD, situs ambiguous, and transposition of the great arteries. It is
also not associated with premature atherosclerotic heart disease.
The Congenital Heart diseases frequently reported in Down syndrome
include Endocardial cushion defect, Ventricular septal defect, Atrial septal
defect(Ostium secundum  type ) and Patent ductus arteriosus.
Endocardial Cushion defect 8
 It is also called AV canal defect. It may be complete or partial. Of all
patients with complete ECD, 30% are children with Down syndrome. Of
children with Down syndrome, 40 % have CHD and 40% of the defects are
ECD.
· Complete AV Canal defect
 Ostium Primum ASD, VSD in the inlet ventricular septum and clefts
in the anterior mitral valve and the septal leaflet of the tricuspid valve
(forming the common AV valve) are present in the complete form. A single
orifice connects the Atrial and Ventricular orifices.
· Partial AV canal defect
  When two AV orifices are present without an Interventricular shunt,
the defect is called partial ECD or Ostium Primum defect.
Ventricular septal defect
The ventricular septum may be divided into a small membranous
portion and a large muscular portion. Muscular septum has three
components-the inlet septum, the trabecular septum and the outlet septum.
· 70% of VSD are Perimembranous 8.
· 5-7% of VSD are outlet defects.
· Inlet defects account for 5-8%.
· Trabecular defects are seen in 5-20% of all VSD.
 The development of pulmonary vascular disease occurs early in Down
syndrome irrespective of the size of the VSD.
Atrial Septal defect
 Three types of ASD exist.
· Ostium Secundum defect.
· Ostium Primum defect. It is isolated in 15% of cases and part of ECD
in the remainder.
· Sinus venosus type.
II   REVIEW OF  LITERATURE
 Marie T. Mulcahy 9 et al studied 235 cases of Down syndrome in a
10-year study of Down syndrome in Western Australia. Cytogenetic studies
performed on 222 subjects confirmed that 95% of cases were Trisomic due
to nondisjunction, 4% were Trisomic due to translocation and 1% was
mosaic.
Wells GL 10 et al in the University of Alabama reviewed the
medical records of 118 newborn infants with Down syndrome. Of 102
infants having echocardiography, 49 (48%) had heart defects; 47 of these
had Trisomy 21 and 2 had unbalanced translocation karyotypes. Of the 53
(52%) who did not have heart defects, all had Trisomy except 1 with a
mosaic karyotype and 1 with a translocation karyotype. The most common
heart malformation was an Atrioventricular canal defect, followed in
frequency by Ventricular septal defect, Atrial septal defect, Patent ductus
arteriosus and Tetralogy of Fallot.
 In a similar study, Bhatia S 11 et al in the All India Institute of
Medical Sciences, New Delhi, evaluated the utility of echocardiography in
assessing the frequency and nature of cardiac malformations in children with
Down syndrome. Fifty cases of chromosomally proven Down syndrome
were studied. Twenty-two (44%) children had heart diseases. Endocardial
cushion defect was the commonest anomaly, followed by Ventricular septal
defect. Three children with heart disease were asymptomatic and had normal
X-ray films of chest and ECG.
Venugopalan P 12et al conducted a prospective study on “Spectrum
of congenital heart defects associated with Down Syndrome in high
consanguinous Omani population.” All children with Down Syndrome
referred to the Clinic from 1995-1998 formed the subjects (Group I).
Children without Down Syndrome or other known associations of CHD seen
at the clinic during the same period served as controls (Group II). Two-
dimensional echo-Doppler studies were performed on both groups and the
results compared. CHD were detected in 54/90 (60%) children in Group I,
compared to 698/2122 (32.9%) in Group II. The common CHD in Group I
included secundum Atrial septal defect (ASD; 18/54), atrioventricular septal
defect (AVSD; 15/54) and ventricular septal defect (VSD; 14/54), and in
Group II included ASD (175/698), VSD (175/698), patent ductus arteriosus
(123/698), pulmonary stenosis (PS; 76/698) and AVSD (35/698). AVSD
was more common (P <0.001) and PS less common (P = 0.03) in Group I.
Aortic stenosis, Coarctation of aorta, transposition of great arteries and
complex heart diseases were not detected. Compared to several studies from
populations with low prevalence of consanguinous marriages, their study
showed a higher frequency of CHD in Down syndrome. A high frequency of
CHD was documented in Down Syndrome children from a population with
widely prevalent consanguinity. AVSD was most frequent in Down
Syndrome. An interesting observation was the relative rarity of some CHD
in the Down syndrome population studied.
Krishnadas Nandagopal 7 et al discussed the Molecular aspects of
Down syndrome. The chromosome 21 contains 225 genes, some of which,
located at the Down Syndrome Critical region (DSCR), are thought to
contribute to the pathogenesis of Down Syndrome, although function of
most of the encoded proteins still remains unknown.
 DSCR contains genes coding for enzymes such as superoxide
dismutase 1 (SOD1), cystathione beta synthase (CBS), glycinamide
ribonucleotide synthase - aminoimidazole ribonucleotide synthase -
glycinamide formyl transferase (GARS-AIRS-GART). The function of
SOD1 is to remove harmful peroxide linkage. In fetal Down Syndrome
brain, an increase in SOD1 activity has been observed, which may cause
oxidative stress as well as gestational lipoperoxidation.Increased CBS
activity may disrupt homocysteine metabolism, since in vitro studies have
shown that increased CBS activity ultimately lead to folate trap.Over
expression of Gars-Airs-Gart gene has been reported in fetal Down
Syndrome brain. Additionally, elevated blood levels of uric acid, xanthine
and hypoxanthine, catabolites of purine metabolism, have also been
observed in Down Syndrome babies.
 Down syndrome cell adhesion molecule gene (Dscam) at 21q22.2-
22.3 is expressed in heart during cardiac development and is implicated in
Down Syndrome related congenital heart disease.Altered expression of
collagen VI alpha 1, located at 21q22.3, may lead to abnormal neuronal
migration since collagen controls cell proliferation and neuronal
differentiation.
Freeman SB 13 et al conducted, The Atlanta Down Syndrome
Project, a population-based study of infants born with Trisomy 21. Of the
227 Down Syndrome infants, 44% had CHD including 45% Atrioventricular
Septal defect (with or without other CHD), 35% Ventricular Septal defect
(with or without other CHD), 8% isolated secundum Atrial septal defect,
7%, isolated patent ductus arteriosus, 4% isolated tetralogy of Fallot, and 1%
others.
Hartyanszky I 14 et al analyzed 359 cases with Down syndrome and
congenital heart defects registered between 1974-1997 in Hungary. The total
death rate was 19.9% (70 cases). Mortality in the operated group (85 cases)
was 10.5% (9 patients), in the non-operated group (274 cases) 22.2% (61
patients). The death rate was lower in the group with early primary
reconstruction (2.3%) than in the group with palliation with reconstruction
(15.3%), or in the group with only palliative procedure (20%). These results
indicate that the life expectancy of infants and children with Down
syndrome and congenital heart disease after early primary reconstructive
procedure is the same as in Down syndrome patients without cardiac defects.
Parvathy U 15 et al investigated the role of cardiac surgery in the
management of CHD in Down syndrome. 21 patients with Down syndrome
and congenital heart defects were operated. Four (19%) patients had
palliative procedures while the rest (81%) underwent primary repair. All
survived the operation. The early mortality was 0, while there were 2 (9.5%)
late deaths. The number of hospitalizations was markedly reduced according
to the parents. Follow-up showed near normal pulmonary artery pressure in
50 percent children with large shunts and a good developmental spurt was
seen in 60 percent. From a purely surgical viewpoint, the prognosis for
children with Down syndrome and congenital heart disease is good.
Calderon-Colmenero J 16 et al  made a retrospective study of
patients with Down syndrome that were surgically treated for correction or
palliation for their congenital heart disease between January 1996 to
December of the 2000 in the National Institute of Cardiology "Ignacio
Chavez ".37 patients were surgically treated. The Ventricular septal defect
was the most frequent one (35%) and six patients (16%) had Atrioventricular
septal defect. Twelve patients (32%) had Patent ductus arteriosus. Three
patients had Tetralogy of Fallot and two had Atrial septal defect. The
surgical treatment was corrective in 89% patients and the average time of
stay in intensive care unit was 2.5 days. The most frequent complication was
rhythm and conduction disorders in 8 patients (22%); three with complete
AV block and the mortality was of 8%. In patients with Down syndrome, it
is important to have a complete clinical evaluation with an eye toward
establishing an opportune surgical treatment.
Mathew P 17 et al. did a long-term follow-up of children with Down
syndrome with cardiac lesions. Two hundred and eighty four patients with
Down syndrome were seen between 1951-1989. A definitive cardiac
diagnosis was established in 47 (41%) patients, of which 38 had long term
follow-up. There were 18 survivors (13 in the surgical group and five in the
nonsurgical group) and 20 nonsurvivors (four in the surgical group and 16 in
the nonsurgical group).They concluded that mortality remains high in such
patients treated nonsurgically due to development of pulmonary vascular
disease and congestive heart failure.
 Shah PS 18 et al. identified seventeen infants with Down syndrome
without structural congenital heart disease who presented with persistent
pulmonary hypertension in the newborn period. Respiratory distress with or
without hypoxia was the presenting feature in these infants. Pulmonary
hypertension resolved in the majority of the survivors. Two infants with
refractory pulmonary hypertension benefited from patent ductus arteriosus
ligation. Autopsies in two infants demonstrated structural lung immaturity.
They  suggested  that infants with Down syndrome are at risk of developing
persistent pulmonary hypertension even in the absence of structural heart
disease and these infants should be followed up until resolution of the
pulmonary hypertension.
Amudha S 19 et al. analyzed the effect of consanguinity on
chromosomal abnormality. Consanguinity was seen in 427 cases (29.14%),
305 cases were confirmed to have Chromosomal abnormality, among them
240 (78.7%) had numerical abnormality and 65 (21.3%) had structural
abnormality. The presence of consanguinity in Chromosomal abnormality
was seen in 53 cases (17%), including 43 (81.1%) with numerical and 10
(18.9%) with structural abnormality. The effect of consanguinity on
Chromosomal abnormality was almost significant, whereas the effect was
not significant for the type of Chromosomal abnormality.
 Studies by Khoury MJ 20 et al showed an upward trend in the birth
prevalence of several congenital cardiovascular malformations.  He
examined changes in the frequency of ascertained cardiovascular
malformations among 532 cases of Down syndrome recorded in the
Metropolitan Atlanta Congenital Defects Program from 1968 through 1989.
Overall, 33% of the cases have reported cardiovascular malformations.
However, the frequency of these defects in Down syndrome infants
increased dramatically from about 20% in the early 1970s to more than 50%
in the late 1980s. These results show improvement in the ascertainment of
cardiovascular malformations among Down syndrome infants in a
surveillance population. They are also consistent with the hypothesis that the
increasing rates of cardiac defects are related, at least in part, to improved
ascertainment of these defects in the population.
Torfs CP 21 et al  conducted a study on Anomalies in Down syndrome
individuals in a large population  based registry. The most common group of
all anomalies were cardiac defects, at a rate of 108 times more common in
Down Syndrome than non-Down Syndrome. The most common defect of all
was the Ventricular septal defect, which is 1000 times more common in
Down Syndrome than in non-Down Syndrome. The paper gives the
incidence of all cardiac defects found in these children. Of the non-cardiac
anomalies, the most common occurring in Down Syndrome were duodenal
atresia at 265-fold, Hirschprungs disease at 101-fold, and annular pancreas
at 430-fold. The paper lists 17 other anomalies more common with Down
Syndrome than non-Down Syndrome.
Paladini D 22 et al assessed the relationship between congenital heart
disease and Down syndrome in utero. In the group of 41 fetuses with known
Down Syndrome, the incidence of CHD was 56% ([Atrioventricular septal
defect (AVSD) 44%, Ventricular septal defect (VSD) 48%], the remainder
having other heart defects). Conversely, considering the incidence of Down
Syndrome in fetuses with CHD, 43% of all AVSD(53% of AVSD with
normal visceral situs) were associated with Down Syndrome, whereas none
of the 39 cases of VSD was associated with Trisomy 21. They have
confirmed that more than half of the fetuses with Down syndrome bear a
CHD, which is an AVSD in 44% of cases. Conversely, 43% of fetuses with
an AVSD have Trisomy 21. For VSD, the situation is controversial, due to
the relatively low detection level of this heart defect at the routine mid-
trimester obstetric scan.
Maria I 23 et al studied paternal age as a risk factor for Down
syndrome. The results obtained in this study give no evidence that paternal
age can be considered a risk factor for the conception of a child with Down
syndrome.
M.M. Mokhtar and M. Abdel-Fattah 24 evaluated the hypothesis that
the Trisomy 21 genome interacts with environmental factors during early
pregnancy to increase the risk for birth anomalies in Down syndrome
infants. A case–control study on 514 infants with confirmed Down
syndrome was carried out from 1 July 1995 to 30 June 2000. Genetic,
biological, environmental and reproductive factors were analyzed. Multiple
logistic regression analysis showed the following factors to be independently
associated with increased risk of congenital heart diseases among Down
syndrome patients: parental consanguinity, maternal parents’ consanguinity,
mother’s antibiotics use in pregnancy, oral contraceptive use and diabetes in
the mother. Fever in the mother during pregnancy was associated with
increased risk of gastrointestinal anomalies.CHD was present in about 40%–
45% of Down syndrome patients. They have been reported in two cases of
partial duplications that include the distal region of q21q22, but have not
been reported in any cases that do not include this region. CHD were the
most common congenital anomalies in patients with Down syndrome in their
study (38.5%).
 Two recent Egyptian studies reported 38.7% and 36.8% CHD among
individuals with Down syndrome. Stoll et al. found CHD in 46.2%, while
Kallen et al.  reported a frequency of 26%. Two other studies, one covering
11 years of ascertainment of Down Syndrome by the California Birth
Defects Monitoring Program and another of 171 Down Syndrome infants in
Texas , found cardiac defects in more than half of the patients.
  The results of their study indicate that AVSD was the commonest type
of CHD among patients with Down Syndrome, followed by Atrial septal
defect and then Patent ductus arteriosus. On comparing their results with
those of other studies, Atrioventricular canal lesions, Ventricular septal
defect and Patent ductus arteriosus were the most frequent lesions in France.
Another study performed in the United States of America reported that the
most frequent lesions were Atrioventricular canal and Tetralogy of Fallot.
Evidence of wide variations in the frequency of CHD and their forms
suggests that environmental factors can play an important role in the
etiology of CHD among Down Syndrome individuals.
Harm Velvis, M.D 3 Pediatric Cardiologist, Albany Medical Center
has shown that CHD is a risk factor for survival in Down syndrome.
• In Sweden 1973-1980 ,10 year mortality was 24%, 44% with CHD,
5% without CHD
• In Japan 1997,25 year survival in Down Syndrome without CHD
92%, Down Syndrome with CHD 75%, Down Syndrome with CHD
and surgery 88% and without surgery 41%.
• In Sweden 1973-97,among 801 AVSD repairs in  Down Syndrome, 5
yr survival was 65% from 1973-77, 90% from 1993-97 and so  Down
Syndrome  is not a risk factor.
• Most recent studies indicate Down Syndrome is not a risk factor for
operative mortality.
• Duke 1997 state that  Down Syndrome is a risk factor for higher
hospital costs.
Frid C25  et al. investigated mortality in relation to congenital
malformations. Medical records from all live born children with Down
Syndrome delivered between 1973 and 1980 in northern Sweden were
studied, and malformations and causes of death were recorded. Out of the
219 children included in the study, a congenital heart defect was reported in
47.5% of subjects, 42.1% of whom had complete Atrioventricular Septal
defect. Gastrointestinal tract malformations were present in 7.3% of
subjects, and were frequently associated with a cardiac malformation and a
very high mortality rate. Other major and minor congenital anomalies were
present in 5.5% and 5.5% of subjects, respectively. In the 14.5-year follow-
up of 213 children, the rate of survival was 75.6%. Mortality rates within
one and 10 years after birth were 14.6% and 23.5%, respectively. Mortality
within 10 years differed significantly between children with (44.1%) and
without (4.5%) a congenital heart defect. A very high mortality rate was
observed among children with a congenital heart defect, especially when it
was combined with a gastrointestinal malformation.
Amark K, Sunnegardh J.26 described the evaluation, decision
making, and care of children with a complete Atrioventricular Septal defect.
Denial of surgery without obvious medical reasons was more common in the
early years, as was parental refusal of offered surgery and institutional care
of the children. Improved results in later years encouraged surgical treatment
for all these patients, but more liberal attitudes towards use of
echocardiography as a screening method for all newborns with Down
syndrome made it possible to plan for correction within the 1st months of
life.
HB Laursen 27 , found eighty cases of Down syndrome with congenital
heart disease among 1504 children under the age of 15 years. The most
common cardiac anomaly, Ventricular septal defect was found in 49 per cent
of the 80 cases studied, while the second most frequently encountered
anomaly, common Atrioventricular canal was found in 15%.Pulmonary
hypertension was found in all of 24 cases of Ventricular septal defect and in
7 of 9 cases of common Atrioventricular canal. The cumulative survival of
upto 10 years was 64% for girls and 49% for boys. Death was most
commonly the result of pulmonary complications, which occurred in 22 out
of the 34 patients who died.
III  STUDY JUSTIFICATION
 The incidence of congenital heart defects among Down syndrome
cases varies from 30 to 65 % in previous studies and the incidence in our
setting can be calculated.
 The pattern of congenital heart defects  varies among geographic areas
and the pattern of CHD in our tertiary care centre can be highlighted.
 This study will throw light on the various factors like maternal age,
order of birth, consanguinity of parents, maternal genetic compositions etc.
which are likely to influence the expression of CHD in Down syndrome.
 The overall outlook for individuals with Down syndrome has
improved dramatically. Many adult patients are healthier, they are better
integrated into society, and they have increased longevity than before.
Patient education on career selection and prenatal testing in subsequent
pregnancies will also form part of the study.
IV OBJECTIVE OF THE STUDY
  To determine the incidence and pattern of congenital heart
defects in children with karyotypically proved Down syndrome attending a
tertiary care centre.
V   MATERIALS AND METHODS
1.  Study design  : Descriptive study
2.  Place of Study   : Department of Cardiology,
Pediatric wards and Genetic
clinic of Institute of Child Health and
Hospital
for children,Egmore,Chennai-8
3.  Study Period  : August 2004 – December 2005
4.  Study Population  :
Inclusion criteria  :  karyotypically proved
                               Down syndrome
5. Sample size   : 112
Manoeuvre :
All suspected cases of Down syndrome in the age group of 3 months -
12 years,fulfilling the clinical diagnostic criteria will be subjected to
karyotyping.All karyotypically proved cases will be included in the study.
After a detailed history and physical examination, the  cases will be
subjected to Chest X-ray, ECG and Two dimensional Echocardiography
with colour Doppler by experienced Paediatric Cardiologist using Hewlett
Packard Sonos 2000 phased array imaging system with 5.0 and 3.7 MHz
transducers.
Statistical analysis was done using chi square test and p value <0.05 is
considered significant.
VI   OBSERVATIONS
112 Down syndrome cases were recruited into the study. Among them
55 cases had congenital heart disease (CHD).
Table 1
FREQUENCY OF CHD IN DOWN SYNDROME
No. of Down syndrome cases studied 112
No. of cases with CHD 55
Frequency of CHD in Down syndrome 55/112 x100 = 49.1%
 49.1% of cases had congenital heart defects.
Table 2
SEX DISTRIBUTION
CHD No CHD Total
Sex
n % n % n %
Male 33 55.0 27 45.0 60 100
Female 22 42.3 30 57.7 52 100
Total 55 49.1 57 50.9 112 100
 60 male cases and 52 female cases were recruited into the study with a
male-female ratio of 1:0.87.
It was found that 55 % of male Down syndrome cases had CHD,
where as only 42.3 % of female cases had CHD.The p value of 0.19 is not
statistically significant.
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 Among 112 cases, the male-female ratio was 1:0.87.Among the 60
males, 33 had CHD and among the 52 females only 22(42.3%) had CHD.
Table 3
GENETIC COMPOSITION AMONG CASES
CHD NO CHD Total
karyotyping
n % n % n %
Non-disjunction 51 49.5 52 50.5 103 100
Translocation
(14,22)
2 40.0 3 60.0 5 100
Translocation
            (21,22)
2 66.7 1 33.3 3 100
Mosaicism 0 0 1 100 1 100
 About 92% (103/112) of cases belonged to Non-disjunction, among
which 49.5% had CHD.Translocation was noted in 8 cases (7%).About 67%
of cases with Translocation (21,22) had CHD.Mosaicism is noted in one
case which did not have any CHD.The p value of 0.68 is not statistically
significant.
Table 4
ORDER OF BIRTH
CHD NO CHD Total
Birth order
n   % n       % n        %
First 13 31.7 28 68.3 41 100
Second 22 51.2 21 48.8 33 100
Third
and above
20 71.4 8 28.6 28 100
31.7% of Down syndrome children born of the first order had CHD.In
the second order birth about 51.2% cases had CHD whereas 20 cases
(71.4%) born of the third order had CHD.The p value of 0.005 is statistically
significant.
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 It is observed that about 71.4% of cases belonging to the third order
and above had CHD, whereas it is only 31.7% in the first order and 51.2% in
the second order births.
Table 5
CONSANGUINITY OF PARENTS
CHD NO CHD TOTAL
Consanguinity
n % n % n %
2nd degree 3 100 0 0 3 100
3rd degree 18 58.1 13 41.9 31 100
Non -
consanguinous 34 43.6 44 56.4 78 100
All the 3 cases (100%) of Down  syndrome born of 2nd degree
consanguinous parents had CHD and 58.1% of cases born to 3rd degree
consanguinous parents had CHD.It dropped to 43.6% when both parents
were non-consanguinous.The p value is 0.08.
Table 6
MATERNAL AGE
CHD NO CHD Total
Maternal age
n % n % n %
<    = 20years 4 66.7 2 33.3 6 100
21 - 25 11 30.6 25 69.4 36 100
26 – 30 25 51.0 24 49.0 49 100
31 and above 15 71.4 6 28.6 21 100
66.7% of Down syndrome cases born to mothers in the age <20years
had CHD .In the maternal age group of  21-25 years, 30.6 % of cases and in
the age group of 26-30 years, 51% of cases had CHD.When the maternal age
is above 31 years the chances of CHD in Down syndrome increases to
71.4%.The calculated p value of 0.02 is statistically significant.
Table 7
PATERNAL AGE
CHD NO CHD Total
Paternal age in
years n % n % n %
21- 30 20 39.2 31 60.8 51 100
31 –40 33 55.9 26 44.1 59 100
41& above 2 100 0 0 2 100
 Tabulation of Paternal age shows that, in the age group of 21-30 years
the risk of being born with a CHD is 39.2%.But in the age group of 31-40
years the risk rises to 55.9% and when the age is 40 and above there is 100%
chances of CHD.The p value was calculated to be 0.08.
Table 8
MATERNAL GENETIC COMPOSITION
CHD NO CHD Total
n % n % n %
Normal 54 48.6 57 100 111 100
Abnormal 1 100 0 0 1 100
 The chromosomal pattern of mothers of children with Down
syndrome was abnormal in only one case. It was a balanced translocation
and she was a carrier with chromosomal pattern of 45XX,-14,-21(i.e.) one
14 chromosome, one 21 chromosome, and one fused 14, 21 chromosome
giving rise to a total of 45 chromosomes and was phenotypically normal.
The Down child born to that carrier mother had CHD- Endocardial cushion
defect. The Chromosomal pattern in the remaining mothers was normal. The
p value of 0.49 is not statistically significant.
Table 9
H/o PREVIOUS ABORTION
CHD NO CHD TOTALH/o previous
abortion
n % n % n %
Yes 11 68.8 5 31.2 16 100
No 44 45.8 52 54.2 96 100
Among them 112 cases,16 mothers gave history of previous abortions,
among which 11 cases (68.8%) had CHD.In the remaining 96 cases, CHD
was present in 44 cases(45.8%).The p value was calculated to be 0.11.
Table 10
CHD IN DOWN CHILDREN BORN
AFTER PREVIOUS ABORTION IN MOTHER
 Among the 11 cases born after  previous abortions in the mother, 5
(45.5%) had Atrial septal defect. Ventricular septal defect,Patent ductus
arteriosus and Tetralogy of Fallot were detected in 2 cases each.
CHD
No. of cases
Atrial septal defect
(ostium secundum type) 5
Ventricular septal defect
2
Patent ductus arteriosus 2
Tetralogy of Fallot 2
Total 11
Table 11
FAMILY H/O DOWN SYNDROME
CHD NO CHD TOTALFamily H/o
Down
syndrome n % n % n %
Yes 1 33.3 2 66.7 3 100
No 54 49.5 55 50.5 109 100
 In 3 cases family history was positive, i.e. there was a previous
Down syndrome child in the family. Among them 1 case had CHD and the p
value of 1.00 is not statistically significant.
Table 12
ASSOCIATED FINDINGS
Non cardiac anomaly n %
None 104 92.9
Cryptorchidism 3 2.7
Hypothyroidism 3 2.7
Hirschprungs disease 1 0.9
Neonatal cholestasis 1 0.9
 In 92.9 % of cases included in the study, no major associated
finding was detected. Remaining 7.1% had some form of noncardiac
anomaly. Three each had Hypothyroidism and Cryptorchidism and one case
of Hirschprungs disease and another case of Neonatal cholestasis was
detected.
Table 13
PATTERN OF CHD ASSOCIATED WITH NONCARDIAC
ANOMALIES
 8 cases among the 112 cases had  non cardiac anomalies.Among them
two did not have any CHD. Ventricular septal defect, Endocardial cushion
defect and  Patent ductus arteriosus were detected in 2 cases each.
The case with Hirschprungs disease had a Ventricular septal
defect. Two cases of Hypothyroidism had Endocardial cushion defect and
another had a Ventricular Septal Defect.Patent ductus arteriosus was noted
in 2 cases of  Cryptorchidism.
CHD
No of cases
    No CHD 2
Ventricular septal defect 2
Endocardial cushion defect 2
Patent ductus arteriosus 2
Table 14
PATTERN OF CHD IN DOWN SYNDROME
S.No CHD N %
1 Ventricular Septal defect 19 34.5
2
Endocardial cushion defect
(Complete & Partial)
12 21.8
3 Atrial Septal defect (OS type) 11 20.0
4 Patent ductus arteriosus 8 14.5
5 Tetralogy of Fallot 3 5.4
6 Others 2 3.6
Total 55
 Ventricular Septal defect is the most common defect identified in
34.5 % of cases with CHD followed by Endocardial cushion defect in 21.8%
and Atrial Septal defect in 20% of cases. Patent ductus arteriosus was
detected in  14.5% of cases.Tetralogy of Fallot was found in 2 cases and one
case had Coarctation of Aorta and another had Dextrocardia with situs
inversus totalis.
Table 15
UNIVARIATE ANALYSIS
Variable OR 95% C.I p-value
Order of birth
1st
2nd
3rd & greater
1.0
2.3
5.4
Reference
0.9,5.5
1.9 , 15.4
0.01
Maternal age
<= 20 years
21-25 years
26-30 years
31-35 years
4.5
1.0
2.4
5.7
0.7 , 28.6
Reference
1.0 , 5.8
1.7 , 18.5
0.03
Order of birth and maternal age are statistically significant risk factors
for the expression of CHD in Down Syndrome.
Table 16
MULTIPLE LOGISTIC REGRESSION
Variable OR 95% C.I p-value
Order of birth
1st
2nd
3rd & greater
1.0
2.0
4.2
Reference
0.8 , 5.1
1.4 , 12.9
0.04
Maternal age
<= 20 years
21-25 years
26-30 years
31-35 years
5.1
1.0
1.9
3.5
0.8 , 33.5
Reference
0.8 , 4.9
1.0 , 12.4
0.13
 When evaluated using multivariate analysis, Order of birth is the
only significant risk factor for the expression of CHD in Down syndrome.
Karyotyping image of Trisomy 21
There is an extra chromosome 21 accounting for the Trisomy.
VII   DISCUSSION
Congenital heart disease is the common cause for  long term
morbidity and mortality in Down syndrome. Between 40-50% of babies with
Down syndrome have congenital heart defects 28. Of  these 30-40% have
complete Atrioventricular septal defects. Most AVSD can be  successfully
treated if the diagnosis is made and the baby referred for full corrective
surgery  before irreversible pulmonary vascular disease is established.
 The incidence of Congenital heart defects in our present study is
49.1% .Various published studies have reported  frequencies ranging from
30-65% 17..Studies by Wells GL 10 et  al in the University of Alabama
showed an incidence of 48% close to our statistics.  In a similar study by
Bhatia S 11 et al in the All India Institute of Medical Sciences, New Delhi,
the incidence was 44%.
 The incidence of CHD  in Down syndrome varies among geographical
areas. The incidence of CHD in our present study is comparable to that
conducted in Alabama, Atlanta,  France and     Saudi Arabia.
Table 17
Comparison of the incidence of CHD in Down Syndrome17
in various places
The male-female ratio in the present study is 1: 0.85 which
corresponds to the study done by Venugopalan 12 et al in Oman.55% of
male children with Down syndrome had CHD in our present study whereas
only 42.3% of female children had CHD.So the possibility is more for a
male child with a Down syndrome to be born with a CHD but it is not
statistically significant.
S.No Place of study %
1 Present study 49.1
2 Alabama 48
3 Atlanta 44
4 Australia 33
5 California 56
6 France 46
7 Oman 60
8 Saudi Arabia 48
9 Turkey 65
In 92% of cases, the cause for Down syndrome is a Non- disjunction.
Half of them had CHD.A translocation (14,21) was found in 5 cases and 40
% of them had CHD.Translocation(21,22) was detected in 3 cases and 2 of
them had CHD.One child was found to be mosaic and no CHD was detected.
In a study by Wells GL 10 et al in the University of Alabama, 49 (48%) had
heart defects; 47 of these had Trisomy 21 and 2 had unbalanced
translocation karyotypes.Of the 53 (52%) who did not have heart defects, all
had Trisomy except 1 with a mosaic karyotype and 1 with a translocation
karyotype.So a translocation carries more risk of being born with a CHD.
 As the birth order of the child increases, the chances of being born
with a CHD also increases. In our present study about 71% of Down
syndrome born of the third order had CHD against 31.7% and 51.2% in the
first order and second order respectively.This may be compounded by the
maternal age which increases as the order of birth increases. The p value is
0.005 which is statistically significant.
 A case–control study on 514 infants with confirmed Down syndrome
by M.M. Mokhtar and M. Abdel-Fattah 24 evaluated the hypothesis that
the Trisomy 21 genome interacts with environmental factors during early
pregnancy to increase the risk for birth anomalies in Down syndrome.
Multiple logistic regression analysis showed the following factors to be
independently associated with increased risk of congenital heart diseases
among Down syndrome patients: parental consanguinity, maternal parents
consanguinity, mother’s antibiotics use in pregnancy, oral contraceptive use
and diabetes in the mother.
 Consanguinity increases the risk of CHD in the general population.
Likewise when the Down syndrome child is born of consanguinous marriage
it has more chances of being born with a CHD.In our study all the   3 cases
of  2nd degree consanguinity had CHD.58 % of cases born of  3rd degree
consanguinity had CHD.Among non-consanguinous parentage only 43%
had CHD. Consanguinous marriage is common in Arab countries, exceeding
50% in some communities. In a study by Venugopalan 12 et al in Oman,it
was found that in high consanguinous areas the incidence of CHD in Down
is more like in Turkey where it is 65% and in Oman it is 60%.
 As maternal age advances, the risk of  giving birth to a Down
syndrome child also increases.35 years is taken as the cut off, above which
prenatal testing is mandatory. In our present study, in the mother age group
of < =20 years,66% of Down syndrome babies born had CHD.This may
because of the small proportion (6) of mothers in that age group. In the age
group 21-25 it is 30% and in 26-30 it is 51%.The risk is higher in the age
group more than 31 years, where 71 % of babies born had CHD.It is
statistically significant.
 Studies by Maria I 23 et al give no evidence that paternal age can be
considered a risk factor for the conception of a child with Down
Syndrome.In our study when the paternal age was between 21-30 years, the
incidence of CHD was 39% and in the 31-40 age group it was  55%.In 2
cases, the father age was above 40 years and both of them had CHD.It is not
statistically significant.
 Genetic pattern was abnormal in the mother of one child. It was a
balanced translocation. She was asymptomatic.The Down child born to that
mother had CHD and is statistically insignificant. Paul J. Benke 29 showed
in about one-fourth of translocation Down Syndrome individuals, the
translocation is inherited. When it runs in families, the carriers are usually
unaware that they have a translocation because there are no problems for the
balanced translocation carrier. Only with the birth of a Down syndrome
child or Down Syndrome fetus by miscarriage, does the couple find out one
parent is a translocation carrier.
 Sixteen mothers gave history of previous abortions before the birth of
the Down child.Among them 11 cases (68%) had CHD.Atrial Septal defect
was detected in 5 among the 11 cases and Ventricular septal defect,
Endocardial cushion defect and Patent ductus arteriosus in 2 each.
 In 3 occasions, there was a previous Down syndrome child in the
family.CHD was found in one out of the three cases.
 Hypothyroidism(2.7%) and Cryptorchidism(2.7%) was detected in 3
cases each.One child had Hirschprungs disease(0.9%).93% of cases were
free of associated non-cardiac  abnormalities. The reported incidence of
gastrointestinal anomalies by Frid C25  et al is 7.5%.The low incidence
reported in our study may be due to the early operative mortality associated
with these lesions.
 In our present study Ventricular septal defect(VSD) is the most
common abnormality accounting for 34.5% of CHD followed by
Endocardial cushion defect(22%).Even though most studies point to
Atrioventricular septal defect(AVSD) as the most common abnormality,
there are studies depicting VSD as the most common defect.
 HB Laursen 27 , found eighty cases of Down syndrome with
congenital heart disease among 1504 children under the age of 15 years. The
most common cardiac anomaly, Ventricular septal defect was found in 49
per cent of the 80 cases studied, while the second most frequently
encountered anomaly, common Atrioventricular canal was found in 15%.
Paladini D 22 et al assessed the relationship between congenital heart
disease (CHD) and Down syndrome  in utero. In the group of 41 fetuses with
known Down syndrome, the incidence of CHD was 56%    [Ventricular
septal defect  in 48%, Atrioventricular septal defect (AVSD) in 44% and the
remainder having other heart defects].These results are comparable with our
study. In Hong Kong, studies report 12 Ventricular septal defect as the most
common anomaly and in Turkey the most common anomaly is Atrial septal
defect.
 A  study by Bhatia S 3 et al in the All India Institute of Medical
Sciences, New Delhi, on fifty cases of chromosomally proven Down
syndrome showed twenty-two (44%) children had heart diseases.
Endocardial  cushion   defect was the commonest anomaly, followed by
Ventricular septal defect.
Torfs CP 21 et al  conducted a study on Anomalies in Down
syndrome individuals in a large population  based registry. The most
common group of all anomalies were cardiac defects, at a rate of 108 times
more common in Down Syndrome than non-Down Syndrome. The most
common defect of all was the Ventricular septal defect, which is  1000 times
more common in Down syndrome than in        non-Down Syndrome.
Table 18
Comparison of CHD in Down Syndrome from various studies
Study by
% of
CHD
Most common Cardiac
anomaly
%
1 Present study 49.2 Ventricular septal defect 34.5
2 Freeman SB 13 et al 44 Endocardial cushion defect 45
3
Calderon-Colmenero
J16 et al
%NR Ventricular septal defect 35
4 Paladini D 22 et al 56 Ventricular septal defect 48
5 Frid C 25 et al. 47.5 Endocardial cushion defect 42.1
6 Venugopalan P 12 et al 60 Endocardial cushion defect %NR
7 Bhatia S  11 et al 44 Endocardial cushion defect %NR
8 Wells GL 10 et al 48 Endocardial cushion defect %NR
9 HB Laursen 27 et al %NR Ventricular septal defect 61
% NR= percentage  not reported in the study.
 The frequency of Patent ductus arteriosus reported in our study is 14.5
% and that of Tetralogy of Fallot is 5.4% , which is similar to previous
reports12. Another finding similar to other reports is the absence of certain
CHD (left heart obstructive lesions, transposition of the great arteries and
complex CHD).It is possible that Down syndrome does not have significant
role in the pathogenesis of these lesions.
VIII  SUMMARY AND CONCLUSION
· Incidence of Congenital Heart defects in Down syndrome is 49.2%.
· Ventricular Septal defect(34.5%) is the most common CHD followed
by Endocardial cushion defect(21.8%).
· Incidence of CHD is more in a male with Down syndrome(55%) than
in a female(42.8%).
· Down syndrome is due to non-disjunction in 92% of cases and
translocation in 7% of cases.1% is due to mosaicism.Percentage
of CHD  was    more   in   translocation (67%) than due   to
non-disjunction(49.5%).
· As the order of birth increases, the chances of being born with a CHD
also increases.
· Advanced maternal age is not only a risk factor for increased
incidence of Down syndrome, but also an independent risk factor for
CHD.Percentage of CHD  when maternal age is above 30 years is
71%.
· Risk of CHD in down syndrome is 100% when born to 2nd degree
consanguinous  parents and 58.1%, if it is 3rd degree and 43.6% if
non-consanguinous.
· 68.8% of Down syndrome cases born after a previous history of
abortion in the mother had some form of CHD.Atrial septal defect was
detected in 5 cases among the 11.
· 7.1% of cases had some form of noncardiac anomaly.
· Hypothyroidism(2.7%) and Cryptorchidism(2.7%) was detected in 3
cases each. One child had Hirschprungs disease(0.9%) and another
had Neonatal cholestasis syndrome(0.9%).
Congenital Heart Disease in Down syndrome
PROFORMA
1. Name      :  I.P.No      :
2. Age         :    Genetic No  :
3. Sex          :      CD No       :
4. Place       :
5. Pedigree Chart
6. Mothers age at conception: Fathers age:
7.Family History of Down syndrome:
8.History
breathing difficulty    :
feeding problems    :
facial puffiness/pedal edema  :
cyanosis      :
recurrent respiratory tract infection :
9.Physical exam
  Respiratory distress :
  Cyanosis   :
  Clubbing   :
Auscultation    :
10. Karyotyping:
  Case     :
      Parents   :
11. Echo finding:
12. Associated abnormalities:
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